Polar Body Emission Requires a RhoA Contractile Ring and Cdc42-Mediated Membrane Protrusion  by Zhang, Xuan et al.
Developmental Cell
ArticlePolar Body Emission Requires a RhoA Contractile
Ring and Cdc42-Mediated Membrane Protrusion
Xuan Zhang,1,5 Chunqi Ma,1,5 Ann L. Miller,2 Hadia Arabi Katbi,1,3 William M. Bement,2 and X. Johne´ Liu1,3,4,*
1Ottawa Health Research Institute, Ottawa Hospital, 725 Parkdale Avenue, Ottawa, ON K1Y 4E9, Canada
2Department of Zoology, University of Wisconsin-Madison, 1117 West Johnson Street, Madison, WI 53706, USA
3Department of Biochemistry, Microbiology and Immunology
4Department of Obstetrics and Gynecology
University of Ottawa, Ottawa, ON K1N 6N5, Canada
5These authors contributed equally to this work
*Correspondence: jliu@ohri.ca
DOI 10.1016/j.devcel.2008.07.005SUMMARY
Vertebrate oocyte maturation is an extreme form of
asymmetric cell division, producing a mature egg
alongside a diminutive polar body. Critical to this
process is the attachment of one spindle pole to
the oocyte cortex prior to anaphase. We report
here that asymmetric spindle pole attachment and
anaphase initiation are required for localized cortical
activation of Cdc42, which in turn defines the surface
of the impending polar body. The Cdc42 activity zone
overlaps with dynamic F-actin and is circumscribed
by a RhoA-based actomyosin contractile ring. During
cytokinesis, constriction of the RhoA contractile ring
is accompanied by Cdc42-mediated membrane out-
pocketing such that one spindle pole and one set of
chromosomes are pulled into the Cdc42 enclosure.
Unexpectedly, the guanine nucleotide exchange fac-
tor Ect2, which is necessary for contractile ring for-
mation, does not colocalize with active RhoA. Polar
body emission thus requires a classical RhoA con-
tractile ring and Cdc42-mediated membrane protru-
sion.
INTRODUCTION
Polar body emission during vertebrate oocyte maturation is an
extreme form of asymmetric cell division (Maro and Verlhac,
2002). In Xenopus oocytes, approximately 2 hr following germi-
nal vesicle (nuclear envelope) breakdown (GVBD), the meta-
phase I spindle assumes a highly asymmetric position with one
pole anchored to the animal pole cortex. In the span of 10–15
min, synchronous separation of chromosome homologs occurs,
followed by lopsided cytokinesis to emit a polar body with a com-
plete set of chromosome homologs and minimum cytoplasmic
content. The condensed egg chromosomes are then organized
into a metaphase II spindle without nuclear envelope reforma-
tion, and the spindle again assumes the same asymmetric con-
figuration, approximately 3 hr following GVBD (Gard, 1992; Ma
et al., 2006).
Maturation promoting factor (MPF) (Masui and Markert, 1971),
a complex of cyclin-dependent protein kinase 1 (Cdk1) and386 Developmental Cell 15, 386–400, September 16, 2008 ª2008 Elcyclin B (Gautier et al., 1990), is thought to be the key enzyme
controlling oocyte maturation. In Xenopus oocytes, the steroid
hormone progesterone activates a signaling cascade that
culminates in abrupt MPF activation (Masui and Markert, 1971)
at the time of GVBD. Within 30 min of GVBD, however, the level
of MPF activity is transiently and partially reduced (Gerhart et al.,
1984), due to polyubiquitination-mediated proteolysis of its reg-
ulatory subunit, cyclin B (Hochegger et al., 2001). The second
phase of MPF activity increase occurs as a result of de novo syn-
thesis of cyclin B, approximately 2.5 hr after GVBD (Hochegger
et al., 2001; Mendez et al., 2002), coinciding with the oocyte’s
entering metaphase II arrest (Gerhart et al., 1984; Ma et al.,
2003). Therefore the first phase of MPF activation drives the
oocyte into metaphase I and the second phase is responsible
for metaphase II entry and arrest. The partial (instead of com-
plete) inhibition of MPF appears to be uniquely required to
prevent reformation of the nuclear envelope, as well as to inhibit
DNA replication between metaphase I and metaphase II (Iwabu-
chi et al., 2000).
We recently demonstrated that activation of the small G pro-
tein Cdc42 is required for cytokinesis during first polar body
emission inXenopus oocytes. Cdc42 is first activated at the spin-
dle pole-cortex contact site at the start of cytokinesis. The activ-
ity zone of Cdc42 defines the inner boundary of a ring of Rho A
activity; the latter patterns the cytokinetic contractile ring (Ma
et al., 2006). Inhibition of Cdc42 activation, with a dominant-neg-
ative Cdc42 mutant (Cdc42N17), abolishes first polar body emis-
sion by inhibiting cytokinesis without affecting asymmetric spin-
dle positioning or chromosome separation. In the current study,
we have addressed two questions: (1) How is activation of Cdc42
regulated? (2) How does Cdc42 activity coordinate with RhoA
activity in controlling the contractile ring? Our data support the
following conclusions: (1) Perpendicular configuration of the
metaphase I spindle at the onset of anaphase is required for
Cdc42 activation. (2) Polyubiquitin-mediated cyclin B degrada-
tion is required for anaphase I and subsequent Cdc42 activation.
(3) The guanine nucleotide exchange factor, Ect2, is required for
RhoA contractile ring formation. (4) Cdc42 and RhoA form mutu-
ally exclusive activity zones during polar body emission through
both stimulatory and inhibitory interactions. (5) Cdc42 and RhoA
make distinct contributions to the process of polar body emis-
sion: RhoA templates formation of the contractile ring, which is
enriched in myosin-2 and stable F-actin and which drives con-
traction, while Cdc42 templates a cap of highly dynamic F-actinsevier Inc.
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outpocketing.
RESULTS
Cyclin BDegradation Is Required for Anaphase Initiation
and for Cdc42 Activation
Cdc42 activation is first observed at the spindle-cortex contact
site shortly (within a few minutes) following anaphase initiation
(Ma et al., 2006), suggesting that activation of Cdc42 might be
temporarily and mechanistically coupled to anaphase. We
wished to inhibit anaphase without altering spindle assembly
or the perpendicular spindle attachment to the oocyte cortex.
The role of cyclin B degradation and the resultant loss of Cdk1
activity during amphibian meiosis is controversial. While it has
been reported that stabilization of Cdk1 activity via prevention
of cyclin B destruction does not prevent polar body formation
(Taieb et al., 2001; Peter et al., 2001), it has also been reported
that experimental stabilization of Cdk1 by other means does
block polar body emission and that this blockade can be relieved
by Cdk1 inhibition (Gorr et al., 2006). We therefore reinvestigated
the role of cyclin B degradation on polar body emission. We em-
ployed a truncated form of cyclin B1 (DN cyclin B1 [Gross et al.,
2000]) that lacks the destruction box required for APC-targeted
degradation, as opposed to the destruction peptide employed
by Peter et al. (2001). Injection of DN cyclin B1 mRNA efficiently
eliminated the transient inactivation of MPF seen in control oo-
cytes (Figure 1A). Oocytes injected with DN cyclin B1 underwent
progesterone-induced GVBD indistinguishably from control
oocytes (data not shown). However, oocytes injected with DN
cyclin B1 mRNA failed to emit the first polar body (Figure 1B).
Similarly, injection of methylubiquitin effectively inhibited cyclin
B degradation (see Figure S1A available online) and inhibited first
polar body emission (Figure S1B).
We next carried out time-lapse imaging (or 4D imaging [Be-
ment et al., 2003]) experiments to determine the effect of DN cy-
clin B1 on Cdc42 activation in live oocytes, using eGFP-wGBD,
a GFP fusion protein containing the GTPase-binding domain of
WASP (wGBD) that binds only active (GTP-bound) Cdc42 (Sokac
et al., 2003). As shown previously (Ma et al., 2006), control oo-
cytes exhibited Cdc42 activation approximately 2 hr after
GVBD, emitted the first polar body, and then arrested in meta-
phase II indefinitely (Figure 1C, top row, and Movie S1). In con-
trast, DN cyclin B1-injected oocytes failed to activate Cdc42,
and the spindle remained intact and attached to the cortex for
an extended period of time (Figure 1C, bottom row, and Movie
S2). Similarly, methylubiquitin-injected oocytes exhibited intact
metaphase I spindles that remained asymmetrically attached
to the cortex, with no Cdc42 activation (Figure S1C).
Given the controversy regarding whether the transient degra-
dation of cyclin B is required for homolog separation in Xenopus
oocytes (Peter et al., 2001; Taieb et al., 2001), we wished to ob-
serve chromosome dynamics in live oocytes injected withDN cy-
clin B1 mRNA. We employed fluorescent antibodies against
Xenopus Aurora B (see Experimental Procedures) to track en-
dogenous Aurora B, a chromosome passenger kinase (Rogers
et al., 2002). As shown in Figure 1D (and Movies S3 and S4), fluo-
rescent anti-Aur B faithfully tracked chromosomes through the
metaphase I (00:10) to metaphase II (00:52) transition. In addi-Developmetion, fluorescent anti-Aur B also clearly marked the central spin-
dle or spindle midzone (MZ) at anaphase/telophase (arrows,
00:20–00:24), and the midbody following polar body emission
(arrow, 00:28). These data are consistent with previous conclu-
sions based on staining of fixed oocytes of other species (Rogers
et al., 2002; Uzbekova et al., 2008). It is noteworthy that in con-
trast to mitosis in which Aurora B is completely transferred to the
central spindle at anaphase (Ruchaud et al., 2007), in the oocytes
Aurora B persisted with the segregated chromosome homologs
(Figure 1D) (Rogers et al., 2002). Presumably, Aurora B signal
persisted at anaphase I due to the cohesion of sister centro-
meres, which only resolve at anaphase II upon fertilization
(Kudo et al., 2006).
Having established the utility of fluorescent anti-Aur B in track-
ing chromosomes in live oocytes, we followed the fate of chro-
mosomes in oocytes injected with DN cyclin B1. As shown in
Figure 1E, metaphase I spindles remained asymmetrically posi-
tioned against the animal pole cortex for an extended period of
time, with no homolog separation. Similarly, oocytes injected
with methylubiquitin did not separate chromosome homologs
(data not shown). These data clearly indicate that cyclin B deg-
radation is required for anaphase initiation and for Cdc42 activa-
tion.
Securin Degradation Is Required for Homolog
Separation but Not for Spindle Changes during
Anaphase
To directly assess whether homolog separation is required for
Cdc42 activation, we employed a D box mutant of Xenopus Se-
curin (xSecurindm) to inhibit Xenopus separase (Zou et al., 1999).
Injection of mRNA encoding xSecurindm did not interfere with
progesterone-induced GVBD (data not shown). Importantly, oo-
cytes injected with xSecurindm also exhibited the typical biphasic
pattern of MPF activity (Figure 2A) found in control oocytes, indi-
cating that xSecurindm did not interfere with cyclin B degrada-
tion. However, when these oocytes were fixed and examined
for chromosome morphology, it became clear that they too failed
to emit the first polar body (Figure 2B). To further characterize the
effect of xSecurindm on oocyte maturation, we carried out live
oocyte imaging experiments. Although, as expected, chromo-
some separation did not occur (Figure 2C and Movie S5), meta-
phase I spindles in xSecurindm-injected oocytes underwent dra-
matic shortening (00:15–00:24), indicative of ‘‘anaphase A’’ in
which kinetochore microtubules progressively shorten. In the
absence of homolog separation, the spindle eventually resumed
its normal length (00:48). We often observed some chromo-
somes (presumably unresolved chromosome bivalent[s]) break
away temporarily (arrow, 00:33) but quickly rejoin the rest
when the metaphase spindle reassembled, similar to the results
previously obtained in mouse oocytes lacking separase (Kudo
et al., 2006). These results are in contrast to those in oocytes in-
jected with methylubiquitin or DN cyclin B1 in which metaphase I
spindle remained unchanged.
To determine whether Cdc42 activation occurred in xSecur-
indm -injected oocytes, we carried out time-lapse imaging exper-
iments. We consistently observed a small Cdc42 activity zone at
the center of the spindle pole during the period of spindle short-
ening, but this Cdc42 activity zone never expanded into a robust
cap (Figure 2D, lower row, and Movie S7), as it did in controlntal Cell 15, 386–400, September 16, 2008 ª2008 Elsevier Inc. 387
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Cdc42 and Membrane Protrusion in Polar Body EmissionFigure 1. Cyclin B Degradation Is Required for Anaphase Initiation and for Cdc42 Activation
(A) Control oocytes and oocytes injected with DN cyclin B1 mRNA were incubated with progesterone and withdrawn at GVBD, or 1 or 3 hr after GVBD, for MPF
(histone H1 kinase) assays. GV oocytes were not treated with progesterone. Note the transient (1 hr) inactivation of MPF in control but not DN cyclin B1 oocytes.
388 Developmental Cell 15, 386–400, September 16, 2008 ª2008 Elsevier Inc.
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when the metaphase I spindle reassembled (we call this the
metaphase I spindle because chromosome homolog separation
never occurred; see above). These results clearly indicated that,
similarly to mitosis and meiosis in other organisms, homolog
separation in meiosis I in Xenopus oocytes requires Securin deg-
radation. These results also suggest that Cdc42 activation is
coupled to spindle changes during anaphase and not to homo-
log separation per se.
Asymmetric Spindle Positioning Is Required for Cdc42
Activation
As Cdc42 activation only occurs at the spindle pole-cortex con-
tact site (Ma et al., 2006), we wished to determine whether spin-
dle pole-cortex contact was indeed required for Cdc42 activa-
tion. Earlier work by Gard (1992) has indicated that metaphase
I spindle attachment to the oocyte cortex requires an intact cor-
tical actin network. We have previously shown that expressing
C3 ADP ribosyltransferase (Nemoto et al., 1991), a specific and
potent Rho inhibitor, in GV oocytes disrupted cortical actin and
caused metaphase I spindles to ‘‘sink’’ inside the oocyte cyto-
plasm (Ma et al., 2006). To bypass this phenotype and specifi-
cally explore the possibility of inhibiting spindle rotation (Gard,
1992), we injected C3 mRNA 60 min following GVBD when the
metaphase I spindle had assembled near the oocyte surface
(Gard, 1992). As shown in Figure 3A (and Movie S8), at the start
of anaphase (00:20–00:22), the spindle remained parallel to the
oocyte cortex. Interestingly, we also observed Aurora B localiza-
tion between the separating chromosomes, consistent with
spindle midzone association (arrows, 00:30). A short while after
homolog separation, chromosomes recongressed and formed
a single metaphase (II) spindle (we call this metaphase II because
homolog separation had been completed earlier). Significantly,
the active Cdc42 failed to rise above background (Figure 3B).
To determine whether we could further delay Rho inhibition to
specifically inhibit cytokinesis (Bement et al., 2005; Ma et al.,
2006) without affecting spindle rotation (Gard, 1992), we injected
C3 mRNA at 90 min following GVBD. Approximately 30 min after
C3 mRNA injection (or 2 hr after GVBD), anaphase initiated
(Figure 3C, 00:04; evident by the thinning of microtubules in
the middle of the spindle; also see Movie S9), and shortly after,
active Cdc42 appeared at the spindle pole-cortex contact site
(00:08, arrow). However, instead of developing a robust Cdc42
activity cap to enclose the extruding polar body (as is the case
in control oocytes; see above), active Cdc42 was restricted to
the same site for approximately 10 min before disappearing(00:18). These oocytes underwent complete chromosome sepa-
ration (data not shown) but failed to extrude a polar body. Even-
tually, a single metaphase spindle emerged and became at-
tached to the oocyte cortex (Figure 3C, 01:02). Thus, Cdc42
activation requires a bipolar metaphase I spindle with one pole
attached to the oocyte cortex in a perpendicular configuration.
However, because the level of Cdc42 activation never achieved
what was seen in controls, the results also suggest that RhoA
activity is required for full Cdc42 activation (also see below).
Ect2 in Polar Body Emission
To further investigate the functional interaction between Cdc42
and RhoA, we employed a dominant-negative mutant of
Xenopus Ect2 (Tatsumoto et al., 2003). Ect2 has been implicated
as a centralspindlin-associated RhoA GEF in controlling the cy-
tokinetic contractile ring (Tatsumoto et al., 1999; Yuce et al.,
2005), although what role, if any, this GEF plays in vertebrate
polar body emission has not been described. Injection of DN-
Ect2 inhibited polar body emission (87/94 failed, compared
with 0/50 in control oocytes). As shown in Figure 4A, DN-Ect2
abolished formation of the ring-like RhoA activity zone, probed
with eGFP-rGBD (rGBD: the Rho-binding domain of rhotekin,
which binds only the GTP form of Rho [Benink and Bement,
2005]). DN-Ect2 did not affect spindle assembly, spindle-cortex
contact, or homolog separation (Figure 4B and Movies S10 and
S11). Interestingly, like C3 (Figure 3C), DN-Ect2 similarly dimin-
ished but did not eliminate Cdc42 activation (Figure 4C, DN-
Ect2, and Movie S13). Similarly diminished Cdc42 activity was
also observed in oocytes injected with Cdc42N17 (Figure 4C,
Cdc42N17, and Movie S12), agreeing with our previous conclu-
sion that that Cdc42N17 only partially inhibited Cdc42 (Benink
and Bement, 2005; Ma et al., 2006).
To determine localization of Ect2 during polar body emission,
we employed a GFP-tagged Xenopus Ect2 (Ect2-3GFP). Prior to
anaphase initiation, very little specific Ect2 signal was detected
(Figure 5A, 00:00, and Movies S14 and S15). At anaphase,
Ect2 became clearly concentrated to a ring between the two
spindle poles (00:01), reminiscent of central spindle-associated
Aurora B (Figure 1D). In the next few minutes, the central spindle
expanded laterally and attracted more Ect2. The ring started to
constrict (00:09) and closed in less than 10 min (00:17). In oo-
cytes injected with Cdc42N17, Ect2 also became concentrated
at the central spindle, as in control oocytes. However, the Ect2
signal faded without contracting (Figure 5B and Movies S16
and S17; a total of 10 oocytes were imaged in three experiments
and none contracted). Similarly, Ect2 signal was seen in oocytes(B) Control oocytes and oocytes injected with DN cyclin B1 mRNA were treated with progesterone and fixed 3–4 hr after GVBD for chromosome analyses. Oo-
cytes were scored as MII (metaphase II chromosome array and a polar body) or no polar body (PB). Shown are means (percentage of total oocytes examined, with
SEM) of three independent experiments. The total numbers of oocytes in the three experiments are also included in the graph. Shown below are typical chro-
mosome images of the two groups.
(C) A series from a 4D movie of a control oocyte (upper row) and an oocyte injected with DN cyclin B1 mRNA (lower row). These oocytes were also injected with
rhodamine-tubulin (red) and eGFP-wGBD (active Cdc42, green). Note the complete lack of Cdc42 activation, and lack of a polar body (PB), in oocytes injected
with DN cyclin B1 mRNA. Scale bar is 20 mm in all images of this paper. Time (hr:min) zero corresponds to the beginning of the time-lapse experiments, typically
100–120 min after GVBD. In some oocytes, the vitelline membrane (VM) is visible with the fluorescence probes.
(D) A series from a 4D movie of a control oocyte depicting dynamic localization of endogenous Aurora B (Alexa 488 anti-Aurora B, green) and microtubules (rho-
damine-tubulin, red). Arrows indicate spindle midzone (MZ) or midbody (MB). Note that egg (MII) chromosomes (circle) appear much fainter (than polar body
chromosomes) because they are obscured by the dense cytoplasm.
(E) A series from a 4D movie of an oocyte injected with DN cyclin B1 mRNA depicting endogenous Aurora B (Alexa 488 anti-Aur B, green) and microtubules (rho-
damine-tubulin, red). Note the attachment of intact metaphase I spindle to the oocyte cortex for an extended period of time without chromosome separation.
Developmental Cell 15, 386–400, September 16, 2008 ª2008 Elsevier Inc. 389
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organized than those in oocytes injected with Cdc42N17
(Figure 5C and Movies S18 and S19). In contrast, no specific
Ect2 signal was seen in oocytes injected with DN cyclin B1 or
methyl-Ub (data not shown). As expected, DN-Ect2 also com-
pletely eliminated any specific Ect2 signal (data not shown), as
shown in mitosis (Chalamalasetty et al., 2006). These results in-
dicate that the appearance of Ect2 signal at the central spindle is
Figure 2. xSecurindm Inhibits Homolog Separation and Diminishes Cdc42 Activation
(A) Control oocytes and oocytes injected with xSecurindm mRNA were incubated with progesterone and withdrawn at the indicated time for MPF assays, as in
Figure 1A.
(B) Control oocytes and oocytes injected with xSecurindm mRNA were treated with progesterone and fixed 3–4 h after GVBD for chromosome analyses, as in
Figure 1B. Shown are means (percentage of total oocytes examined, with SEM) of three independent experiments.
(C) A series from a 4D movie of an oocyte injected with xSecurindm mRNA depicting endogenous Aurora B (Alexa 488 anti-Aur B, green) and microtubules (rho-
damine-tubulin, red). Note the dramatic shortening of the spindle, without polar body emission.
(D) A series from a 4D movie of a control oocyte (upper row) and that of an oocyte injected with xSecurindm mRNA (lower row). These oocytes were also injected
with rhodamine-tubulin (red) and eGFP-wGBD (active Cdc42, green). Cdc42 activation was diminished but not eliminated (arrow) in xSecurin dm-oocytes.
390 Developmental Cell 15, 386–400, September 16, 2008 ª2008 Elsevier Inc.
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Cdc42 and Membrane Protrusion in Polar Body EmissionFigure 3. Cdc42 Activation Requires Spindle Pole Attachment to the Oocyte Cortex
(A) A series from a 4D movie of an oocyte injected with C3 mRNA 60 min following GVBD to inhibit spindle rotation (Alexa 488 anti-Aur B, green; rhodamine-tu-
bulin, red). Note the complete separation of chromosome homologs with spindle midzone clearly visible (arrows, 00:30), and the subsequent recongressing of all
chromosomes.
(B) A series from a 4D movie showing an oocyte injected with C3 mRNA 60 min after GVBD (eGFP-wGBD, green; rhodamine-tubulin, red). Note the complete
absence of Cdc42 activation.
(C) A series from a 4D movie of an oocyte injected with C3 mRNA 90 min following GVBD (eGFP-wGBD, green; rhodamine-tubulin, red). Note the limited Cdc42
activation (arrow) that did not develop into a robust cap. No polar body formed.associated with spindle changes during anaphase, and not with
homolog separation per se.
Cdc42 Defines the Borders of RhoA Activity
Zones by Inhibiting RhoA
The mutually exclusive zones of active Cdc42 and active RhoA
during polar body formation (Ma et al., 2006) suggested that
Cdc42 may somehow limit the boundaries of the RhoA zone,
as described for single-cell wound healing in frog oocytes (Be-
nink and Bement, 2005). To test this notion, we conducted
time-lapse imaging in oocytes injected with Cdc42N17, to-
gether with probes for active Cdc42 (RFP-wGBD) and active
RhoA (eGFP-rGBD). As shown previously (Ma et al., 2006), in
control oocytes Cdc42 and RhoA formed complementary activ-
ity zones during polar body formation (Figure 6A and Movies
S20–S22). In contrast, in oocytes injected with Cdc42N17,
only residual Cdc42 activation was detected at the spindle
pole-cortex contact site (data not shown, but see Figure 4C,Developmebottom row). Remarkably, RhoA activity was very robust in
these oocytes, with a higher overall level than that in control oo-
cytes (Figure 6B and Movie S23). The organization of the RhoA
zone was strikingly different than in controls: rather than form-
ing a tight ring and closing rapidly, RhoA activity was spread
out in much broader region, and, moreover, much of the active
RhoA localized to discrete structures not seen in controls.
Nonetheless, the RhoA activity zone still contracted and closed
(Figure 6B; 7/15), although in other oocytes (8/15) the RhoA ac-
tivity zone only partially contracted before subsiding (see
Figure 7C).
Cdc42 Controls Actin Polymerization in the Cortex
of the Protruding Polar Body
To better understand the roles of Cdc42 and RhoA in directing
cytokinetic contractile ring formation and constriction, we car-
ried out time-lapse imaging experiments using Alexa 594-G actin
(to visualize dynamic actin polymerization [Burkel et al., 2007])ntal Cell 15, 386–400, September 16, 2008 ª2008 Elsevier Inc. 391
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Cdc42 and Membrane Protrusion in Polar Body EmissionFigure 4. DN-Ect2 Inhibits RhoA Activity and Diminishes Cdc42 Activity
(A) A series from a 4D movie of a control oocyte (upper row) and that of an oocyte injected with DN-Ect2 mRNA (lower row). These oocytes were also injected with
eGFP-rGBD (green) and rhodamine-tubulin (red). Note the absence of RhoA contractile ring in the DN-Ect2 oocyte.
(B) A series from a 4D movie of an oocyte injected with DN-Ect2 mRNA (Alexa 488 anti-Aur B, green; rhodamine-tubulin, red). Note the complete separation of
chromosome homologs and the appearance of midzone Aurora B (arrows) before chromosome recongression. While the deeper chromosome set was difficult to
see in some time points, the associated microtubule remnant was more evident (circle).
(C) A series from a 4D movie of a control oocyte (top row), that of an oocyte injected with DN-Ect2 mRNA (middle row), and that of an oocyte injected with
Cdc42N17 mRNA (bottom row). These oocytes were also injected with eGFP-wGBD (green) and rhodamine-tubulin (red). Note that Cdc42 activation was dimin-
ished but not eliminated in oocytes injected with DN-Ect2 or Cdc42N17.392 Developmental Cell 15, 386–400, September 16, 2008 ª2008 Elsevier Inc.
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Cdc42 and Membrane Protrusion in Polar Body EmissionFigure 5. Dynamic Ect2 Localization during Polar Body Emission
(A) A series from a 4D movie of a control oocyte injected with rhodamine-tubulin (red) and Ect2-3GFP mRNA (green). Ect2 first appears at the central spindle and
ends at the midbody.
(B) A series from a 4D movie of an oocyte injected with Cdc42N17 together with rhodamine-tubulin (red) and Ect2-3GFP (green). Ect2 appears at the central
spindle but fades away without contraction.
(C) A series from a 4D movie of an oocyte injected with xSecurindm together with rhodamine-tubulin (red) and Ect2-3GFP (green). Ect2 signal appears more dis-
organized (than that in [B]) and similarly fades quickly.together with the RhoA activity probe. Remarkably, the RhoA
zone showed relatively little overlap with the dynamic actin, as
the latter was largely confined to a cap over the forming polar
body while the former remained a tight ring at the base of the
forming polar body (Figure 7A and Movie S24). Because the pat-
tern of dynamic actin closely resembled that of active Cdc42, the
experiment was repeated using Alexa 594-G actin and active
Cdc42 probe (eGFP-wGBD). Indeed, the distribution of active
Cdc42 and dynamic actin showed almost complete overlap
(Figure 7B), suggesting that Cdc42 is responsible for promoting
the dynamic actin on the forming polar body surface. Consistent
with this notion, the actin cap virtually disappeared in oocytes
expressing Cdc42N17, while RhoA activity is very robust
(Figure 7C and Movie S25).DevelopmeRhoA Templates the Contractile Ring with Pre-existing/
Formin-Nucleated F-Actin Filaments
The relative dearth of dynamic actin in the region of the RhoA
zone suggested that RhoA and Cdc42 might play complemen-
tary roles during polar body emission, similar to their proposed
role in cell wound repair, wherein the Cdc42 zone is responsible
for directing formation of a region of relatively dynamic actin
while RhoA is responsible for directing formation of a contractile
ring comprising myosin-2 and stable actin (see Discussion). We
therefore assessed the possibility that relatively stable and/or
formin-nucleated F-actin concentrates in the RhoA zone. This
was accomplished by microinjecting oocytes with fluorescent
phalloidin, which, in contrast to fluorescent G-actin, can label rel-
atively stable F-actin or F-actin nucleated by formins (Mandatontal Cell 15, 386–400, September 16, 2008 ª2008 Elsevier Inc. 393
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Cdc42 and Membrane Protrusion in Polar Body EmissionFigure 6. Inhibition of Cdc42 Caused Hyperactivation of RhoA
(A) A series from a 4D movie of a control oocyte exhibiting dynamic and complementary activity zones of RhoA (eGFP-rGBD, green) and Cdc42 (RFP-wGBD, red)
during polar body (PB) formation. MB, midbody.
(B) A series from a 4D movie of a Cdc42N17-injected oocyte with the same two probes as in (A). Only eGFP-rGBD signal was shown. Note that the RhoA activity
zone spreads out in much larger area.and Bement, 2003; Burkel et al., 2007). In contrast to the fluores-
cent G-actin, fluorescent phalloidin showed considerable over-
lap with the constricting RhoA zone (arrows) as well as the sur-
face of the forming polar body (Figure 7D and Movies S26 and
S27), indicating that the RhoA zone controls a pool of F-actin
during polar body emission that differs from that controlled by
Cdc42. In addition, the RhoA-based contractile ring also con-
tained phosphorylated (active) myosin light chain (pMLC, Figures
S2A and S2B), indicating that RhoA templated a classical acto-
myosin contractile ring during polar body emission. In
Cdc42N17 oocytes, very little F-actin signal was observed, ei-
ther with G-actin probe (Figure 7C) or with phalloidin probe
(Ma et al., 2006), despite prominent RhoA activity and associated
pMLC (Figures S2C and S2D). These results suggest the Cdc42
zone somehow influences the supply of F-actin for the RhoA-
based contractile ring.
Cdc42 Controls Polar Body Outpocketing
The above results suggested that during polar body emission,
RhoA templates formation of a classic contractile ring, while
Cdc42 somehow abets this process by templating formation of
a cap of highly dynamic actin. To assess the mechanistic contri-
butions of the latter structure to polar body emission, the effects
of Cdc42 inhibition were monitored in more detail by following
the distribution of both chromosomes and the RhoA activity
zone. In control oocytes, constriction of the RhoA zone occurs
coincident with protrusion of the polar body chromosomes
(Figure 8A, top row, and Movie S29) and outpocketing of the
plasma membrane (Figure S3), resulting in excision of the polar
body. In contrast, when Cdc42 is inhibited, the RhoA zone un-
dergoes a futile, and often partial, constriction, closing over
a flat plasma membrane and trapping both sets of chromosomes394 Developmental Cell 15, 386–400, September 16, 2008 ª2008 Ein the eggs (Figure 8A, middle row, and Movie S28), which even-
tually recongress into a single metaphase spindle (Ma et al.,
2006). Similar but less organized RhoA activity zone was also ob-
served in oocytes injected with xSecurindm, despite the lack of
homolog separation (Figure 8A, bottom row, and Movie S30).
To further investigate the relationship between the RhoA con-
tractile ring and the dynamic Ect2 ring, we employed RFP-Ect2
together with eGFP-rGBD for double imaging. A distinct Ect2
ring could be seen (Figure 8B, 00:02, and Movies S31 and S32)
several minutes before the RhoA contractile ring became evident
(00:08). Surprisingly, the two rings never overlapped. The RhoA
ring appeared at the level of the plasma membrane and appeared
to constrict and close at the plasma membrane. In contrast, the
Ect2 ring first appeared approximately 20 mm below the levels
of the plasma membrane (00:02, arrow), consistent with its spin-
dle (approximately 40 mm in length) midzone position at this point
(before polar body outpocking). As the Ect2 ring constricted, it
also progressively moved up toward the plasma membrane until
it reached the constricting RhoA ring at the midbody (00:14). At
the midbody, it could be seen that the Ect2 signal formed the
core, wrapped around by the active RhoA ring (inset, top right).
DISCUSSION
Coupling of the final step of cell division to proper spindle orien-
tation is an event particularly important for vertebrate female
meiosis. We previously showed that local Cdc42 activation at
the site of spindle pole-plasma membrane contact is an essential
part of this coupling (Ma et al., 2006). Here we have identified
several distinct, but possibly linked, inputs that are needed for
proper Cdc42 activation: spindle rotation, anaphase initiation,
and RhoA activation.lsevier Inc.
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Cdc42 and Membrane Protrusion in Polar Body EmissionFigure 7. Cdc42 Templates a Dynamic F-Actin Cap Corresponding to the Forming Polar Body
(A) Side view of a series from a 4D movie of a control oocyte exhibiting dynamic (d) F-actin signal (Alexa 594-G actin, red) and RhoA activity (eGFP-rGBD, green).
The RhoA contractile ring had very little dynamic F-actin.
(B) A single time point depicting the complete overlap between dynamic (d) F-actin (Alexa 594 G actin, red) and Cdc42 activity (eGFP-wGBD, green) during polar
body emission.
(C) A series from a 4D movie of a Cdc42N17-injected oocyte, with the same two probes as in (A), indicating the lack of a robust dynamic actin cap. Only residual
F-actin signal was detected at the center of the robust RhoA zone, coinciding with the residual Cdc42 activity (Figure 4C, bottom row).
(D) A series from a 4D movie of an oocyte exhibiting both dynamic and stable F-actin (Alexa 594 phalloidin, red) and RhoA activity (eGFP-rGBD, green). Note the
significant overlap of the phalloidin probe with the RhoA contractile ring (arrows). The F-actin signal in the ‘‘roof’’ of the polar body (00:15, bottom row) progres-
sively thins out during latter stage of polar body emission so the top is open, exposing the phalloidin-labeled midbody (arrow, 00:27).Developmental Cell 15, 386–400, September 16, 2008 ª2008 Elsevier Inc. 395
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Cdc42 and Membrane Protrusion in Polar Body EmissionWhile the first of these inputs, anaphase initiation, might seem
like an obvious requirement, in fact this question has been at-
tended by considerable controversy. That is, it has previously
been reported that homolog separation and polar body emission
in frog oocytes represents an anomaly in not requiring polyubi-
quitination-mediated proteolysis (Taieb et al., 2001; Peter
et al., 2001), in contrast to not only homolog separation and polar
body emission in mouse oocytes (Herbert et al., 2003; Kudo
et al., 2006; Terret et al., 2003) but in meiosis of all other organ-
isms including yeast (Kudo et al., 2006, and references therein).
Based on experiments employing three different approaches,
we find that homolog separation in frog oocytes is no exception
in requiring polyubiquitination-mediated proteolysis. More im-
portantly for this study, Cdc42 activation and polar body emis-
sion are likewise dependent on proteolysis-dependent inactiva-
tion of Cdk1 and resultant anaphase initiation. It is not clear why
our results differ from previous studies (Taieb et al., 2001; Peter
et al., 2001), and in particular those of Peter et al. (2001), who not
only monitored polar body emission per se but also employed
some of the same approaches used here. It is possible that in oo-
cytes injected with the D box peptide, overall cyclin B degrada-
tion was inhibited but at the site of the spindles there was suffi-
cient cyclin B degradation (and MPF inactivation) to permit
anaphase (Peter et al., 2001). In contrast, DN cyclin B1 derived
from mRNA injection (in this study) may better maintain MPF ac-
tivity near the spindle to inhibit anaphase since localized transla-
tion of cyclin mRNA on spindles has been previously described
(Groisman et al., 2000). Similarly, we found that anaphase inhibi-
tion by methylubiquitin was dose sensitive, requiring at least
500 ng (Boston Biotech) per oocyte. As Peter et al. (2001) em-
ployed a different source of methylubiquitin, it is difficult to
compare the potency in the two studies. On the other hand,
our results are consistent with those of Gorr et al. (2006), who
found that polar body emission in both frog and mouse oocytes
was prevented when Cdk1 inactivation was blocked, but
could be subsequently rescued via pharmacological inhibition
of Cdk1.
Whereas multiple factors affect Cdc42 activation, the most
critical among them appears to be spindle pole-cortex contact
and anaphase initiation. Specifically, no Cdc42 activation was
observed in oocytes that underwent anaphase while metaphase
I spindles lay parallel to the oocyte cortex (Figure 3B), or in oo-
cytes in which anaphase initiation was inhibited by DN cyclin
B1 (Figure 1C) or methylubiquitin (Figure S1C). Although the tran-Developmesient inactivation of Cdk1 is required for Cdc42 activation, it is
unlikely the direct trigger. In frog oocytes, degradation of cyclin
B occurs shortly after GVBD, and MPF activity reaches the low-
est levels by 60 min after GVBD (Figures 1A and 2A and
Figure S1A), more than an hour before Cdc42 activation is ob-
served. On the other hand, Cdc42 activation is always coupled
temporally (within a few minutes) to anaphase initiation, suggest-
ing that anaphase functions as a trigger for Cdc42 activation.
Specifically, Cdc42 activation is coupled to anaphase-specific
spindle changes (kinetochore microtubule shortening and cen-
tral spindle formation), rather than homolog separation per se
(see Figure 2D). However, full Cdc42 activation and cytokinesis
eventually failed in the absence of homolog separation (in oo-
cytes injected with xSecurindm), reminiscent of the failed cytoki-
nesis induced by inhibition of Cdk1 in the absence of chromo-
some separation during mitosis (Niiya et al., 2005). The dual
determinants (asymmetric spindle pole attachment to the oocyte
cortex and anaphase initiation) thus provide the temporal and
spatial cues for Cdc42 activation, and hence for this unique
form of cytokinesis. In addition, full activation of Cdc42 also re-
quires concomitant RhoA activation; the latter patterns the con-
tractile ring. Without RhoA activation, the Cdc42 activity zone is
restricted to the initial spindle pole-cortex contact site. Exactly
how RhoA activity influences Cdc42 activity is not known. It
may be achieved through a direct mechanism in which the dy-
namic RhoA activity zone helps sustain the expanding and com-
plementary Cdc42 activity zone, or indirectly though the forma-
tion of the nascent structure (forming polar body) in which
Cdc42 activity can grow.
Although Ect2 has been implicated as a GEF for RhoA during
mitotic cytokinesis (Tatsumoto et al., 1999; Yuce et al., 2005), our
data demonstrate the dynamic association of Ect2 with the cyto-
kinetic structures (central spindles and midbody) in live cells.
Notwithstanding the possibility that our GFP-tagged (and RFP-
tagged) Ect2 does not accurately reflect the natural localization
of endogenous Ect2, our data clearly indicated that Ect2 never
overlapped with the active RhoA zone in the oocytes, and there-
fore Ect2 is unlikely a direct activator (GEF) of RhoA during polar
body emission. Interestingly, a recent study (Birkenfeld et al.,
2007) has identified GEF-H1 as the direct GEF to activate Rho
during cytokinesis in HeLa cells. We propose (Figure 8C) that
shortly after anaphase initiation, the spindle pole (microtubule
minus end)-directed activation of Cdc42 is coordinated by the al-
most simultaneous activation of RhoA, possibly by microtubuleFigure 8. RhoA Contracts Nonproductively in Cdc42N17 Oocytes
(A) Top row: Side view of a series from a 4D movie of a control oocyte injected with Alexa 594-anti-Aur B and eGFP-rGBD. Note that the RhoA contractile ring
constricted between the two sets of chromosomes to complete polar body (PB) emission. Middle row: Side view of a series from a 4D movie of an oocyte injected
with Cdc42N17 mRNA, together with the same two probes. RhoA constricted partially, over both sets of chromosomes, resulting in failure of cytokinesis. Bottom
row: Side view of a series from a 4D movie of an oocyte injected with xSecurindm mRNA, together with the same two probes. The RhoA signal appeared disor-
ganized over the unseparated chromosomes before fading away.
(B) A series from a 4D movie of an oocyte injected with RFP-Ect2 (red) together with the Rho activity probe eGFP-rGBD (green). The Ect2 ring never overlaps with
the Rho contractile ring. The inset (top right) depicts an interior view of the core Ect2 ring wrapped around by the RhoA contractile ring at this time point. The
dashed line marks the level of the plasma membrane (and RhoA contractile ring), and arrows indicate the levels of the Ect2 ring. The side view of this series
is slightly tilted (see xyz coordinates) to show the relatively weak RFP-Ect2 signal at earlier time points.
(C) A working model depicting the differential roles and regulation of Cdc42 and RhoA during female meiotic cytokinesis (side view). Cdc42 and RhoA may be
activated by GEFs associated with the spindle pole (microtubule minus ends) and microtubule tips (plus ends), respectively. Cdc42 and RhoA may also function-
ally regulate each other (explained in the text). While the contractile ring (active RhoA and myosin II) has intrinsic contractility independent of Cdc42 function (see
Figure 6B), the apparent constriction of the Ect2 ring (central spindles) is the result of Cdc42-controlled plasma membrane outpocketing, pulling the spindle up-
ward through the constricting contractile ring.ntal Cell 15, 386–400, September 16, 2008 ª2008 Elsevier Inc. 397
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activity dots in oocytes injected with Cdc42N17 (e.g., Figure 6B)
would support this hypothesis. The differential activation of
RhoA and Cdc42 by microtubules, together with a possible di-
rect inhibition of RhoA by Cdc42, could explain the complemen-
tary and mutually exclusive temporal relationship of RhoA and
Cdc42 activity zones during polar body emission. During con-
tractile ring constriction, the role of Cdc42 appears to facilitate
plasma membrane outpocketing (see Figure S3), pulling the
spindle upward through the constricting RhoA contractile ring
(hence the concomitant Ect2 ring constriction) until the central
spindle reaches the constricted contractile ring (Figure 8C). In
oocytes injected with Cdc42N17, the RhoA/myosin II contractile
ring constricts, often partially. However, without the upward pull-
ing of Cdc42, the RhoA constriction is futile and never accompa-
nied by Ect2 ring constriction (Figure 5B). Although Ect2 does not
appear to colocalize with active RhoA during cytokinesis, it is
clearly required for RhoA contractile ring formation during polar
body emission (Figure 4A), as is in mitosis (Tatsumoto et al.,
1999; Yuce et al., 2005). In addition, it is also required for proper
Cdc42 activation (Figure 4C), possibly indirectly through
RhoA. Precisely how Ect2 regulates the contractile ring and its
constriction remains unsolved here and, in our opinion, in mitosis
as well.
The striking overlap of the Cdc42 zone with dynamic F-actin
(Figure 7B) indicated that Cdc42 promotes rapid actin polymer-
ization over the cortex of the protruding polar body. Our analysis
suggests that Cdc42 activity and the highly dynamic actin poly-
merization it promotes are required for the outpocketing of the
plasma membrane. We therefore propose that Cdc42 and the
highly dynamic actin serve to relax the cortex of the protruding
polar body. Such relaxation could be achieved by either
Cdc42-dependent suppression of myosin-2 activity (Mandato
et al., 2000) or if the dynamic F-actin is a relatively poor
substrate for myosin-2 or other crosslinkers by virtue of its short
half-life.
Regardless of exactly how Cdc42 contributes to outpocket-
ing, the results clearly indicate that RhoA and Cdc42 control dis-
tinct but complementary aspects of the cytoskeletal function
during polar body emission. That is, the RhoA zone directs local
formation of a classic contractile ring composed of myosin-2 and
relatively stable F-actin and/or F-actin polymerized via formins,
while the Cdc42 zone directs formation of a spatially distinct re-
gion rich in highly dynamic actin and virtually devoid of myosin-2.
The actomyosin ring, in turn, powers constriction of the contrac-
tile apparatus with the associated plasma membrane, while the
Cdc42 zone promotes outward pocketing of the plasma mem-
brane to enclose the polar body chromosomes. These findings
are fascinating not only in that they help explain how this highly
asymmetric cell division is accomplished but also from the point
of view of their similarity to what might otherwise be considered
a completely different process, namely, repair of the Xenopus
oocyte cortical cytoskeleton following cell damage (Benink and
Bement, 2005). In that system, Rho and Cdc42 are also activated
in complementary zones, but with the opposite organization,
such that the Rho zone is circumscribed by the Cdc42 zone. Fur-
ther, as in polar body emission, the Cdc42 zone in wound repair
directs formation of a region of highly dynamic F-actin, while the
Rho zone directs formation of a contractile ring rich in relatively398 Developmental Cell 15, 386–400, September 16, 2008 ª2008 Elstable F-actin and myosin-2. These observations support the
notion that Rho GTPase activity zones represent conserved sig-
naling mechanisms that are harnessed to regulate diverse acto-
myosin-dependent events (Bement et al., 2006).
This study provides a mechanistic explanation to the question
of how Cdc42 and RhoA work together to accomplish cytokine-
sis. Although polar body emission is a unique form of asymmetric
cell division, it is intriguing to speculate that principles described
in this paper may have wider implications in asymmetric cell di-
vision of other systems.
EXPERIMENTAL PROCEDURES
Plasmid DNA Construction and mRNA Synthesis
The dominant-negative mutant of Cdc42 (Cdc42T17N) and Myc-tagged Botuli-
num C3 toxin have been described previously (Ma et al., 2006). GFP-Utr-CH,
eGFP-wGBD, RFP-wGBD, and eGFP-rGBD constructs have been described
previously (Sokac et al., 2003; Burkel et al., 2007). Full-length Xenopus Ect2
cDNA was a gift from Dr. T. Miki and was inserted into pCS2-C 3GFP or
pCS2-mRFP, resulting in Ect2-3GFP (three copies of eGFP at the C terminus)
or RFP-Ect2, respectively. Dominant-negative Xenopus Ect2 (amino acids 1–
390) was PCR-amplified and inserted into pCS2 vector. The sequence of Se-
curindm (Zou et al., 1999) was PCR-amplified and subcloned into pCS2+HA
(Booth et al., 2002). The destruction box mutant of cyclin B1 plasmid (DN cyclin
B1) (Gross et al., 2001) was a gift from Dr. James Maller. All cDNA constructs
were linearized before in vitro transcription using Ambion’s mMESSAGE kit
(50 capped). mRNAs were dissolved in water to 1 mg per ml. Typically, 10 nl
was injected per oocyte, although mRNAs coding for fluorescent probes often
required concentration calibration for optimum fluorescence quality. C3 mRNA
(Ma et al., 2006) was further diluted to 20 mg/ml in water, and 10 nl was injected
per oocyte at the indicated time following GVBD. Additional information on
chemicals, antibodies, fluorescent probes, and conjugation of antibodies to
Alexa fluorophores is in the Supplemental Data.
Time-Lapse Confocal Fluorescence Imaging of Xenopus Oocytes
Oocytes were typically injected with mRNA and fluorephorescence probes the
day before imaging experiments and incubated overnight in OR2 at 20C. The
injected oocytes were placed in OR2 containing 1 mM progesterone in the
morning and monitored for GVBD (the appearance of the white maturation
spot). Occasionally, we would add progesterone the night of the injection
(with at least 6 hr between mRNA injection and the addition of progesterone),
in which case we would place the oocytes at 16C following the addition of pro-
gesterone. Oocytes were transferred to 20C in the morning and monitored for
GVBD. This maneuver (16C overnight) often saved hours in the morning before
the first oocyte to appear GVBD. GVBD oocytes were individually transferred to
fresh OR2 and further incubated until imaging time. Although individual oocytes
vary, often considerably, in the timing of GVBD following the addition of proges-
terone, we found that they are remarkably synchronized from the first appear-
ance of the GVBD spot to first polar body emission (Ma et al., 2006). Typically,
120 min after the first appearance of GVBD, the oocyte initiates anaphase I, ev-
ident by kinetochore microtubule shortening or chromosome separation (de-
pending on the probes used). Within a few minutes, cytokinesis starts, evident
by the activation of Cdc42 and RhoA (contractile ring). The constriction of the
contractile ring takes less than 10 min, so we typically started imaging 100–
120 min after the appearance of the GVBD spot. Time zero (00:00) corresponds
to the start of the imaging experiments. Oocytes were imaged with a 603oil ob-
jective on a Zeiss Axiovert with a BioRad 1024 laser scanning confocal imaging
system. Time-lapse image series (Bement et al., 2003) were collected at various
time intervals (30 s to 5 min depending on the experiments). Each time point vol-
ume comprised 15–30 image planes 1–3 mm apart. Image series were 3D-ren-
dered using Volocity Presentation Software (Improvision). Some movies were
made by combining more than one image sequence derived from the same oo-
cyte, necessitated by the need to refocus during time-lapse experiments.
Snapshots were taken at the indicated time points, either top view or side
view, of these 3D series. Each of these imaging experiments was performedsevier Inc.
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Cdc42 and Membrane Protrusion in Polar Body Emissionat least three times, each with a different frog on a different day, with multiple
oocytes being imaged on the same day.
SUPPLEMENTAL DATA
Supplemental data include additional Supplemental Experimental Proce-
dures, 3 figures, and 32 movies. The movies are titled according to the corre-
sponding figures shown in the paper. They can be found with this article online
at http://www.developmentalcell.com/cgi/content/full/15/3/386/DC1/.
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